Skip to main content
Signal8

ANAVEX LIFE SCIENCES CORP. (AVXL)

Operating as a clinical-stage biopharmaceutical entity, Anavex Life Sciences Corp. specializes in developing therapeutic drug candidates for various central nervous system (CNS) conditions. Its leading compound, ANAVEX 2-73, is currently in advanced development, undergoing Phase III clinical evaluation for both Alzheimer's disease and pediatric Rett syndrome. This same drug is also in Phase II trials for Parkinson's disease and is being explored in preclinical studies for a wider range of disorders, including epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. Another significant drug candidate, ANAVEX 3-71, has progressed to Phase I clinical trials for frontotemporal dementia and other forms of dementia, with additional preclinical investigation underway for neurodegenerative illnesses like Alzheimer's and Parkinson's. The company's earlier-stage portfolio includes ANAVEX 1-41, a sigma-1 receptor agonist targeting depression, stroke, Parkinson's, and Alzheimer's diseases; ANAVEX 1066, a mixed sigma-1/sigma-2 ligand with potential applications in neuropathic and visceral pain; and ANAVEX 1037, aimed at treating prostate and pancreatic cancers. Anavex Life Sciences Corp. was founded in 2004 and maintains its headquarters in New York, New York.

Sector: Biological Products, (No Diagnostic Substances)

Industry: Biotechnology

Anavex Life Sciences Corp. logo

Anavex Life Sciences Corp.

NASDAQ:AVXLHealthcare
-8.46%$1.19
AH$1.22+2.52%vs close
Mkt Cap$110.31M
Float92.67M
O/S92.7M
Vol
$ Vol
RVOL
Inst Own39.6%
SI13.5%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$46.38M
Total Assets$103.81M
Free Cash Flow-$39.04M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$94.87M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
  1. 1:4Reverse split
    Oct 7, 20154 shares → 1
Balance Sheet Details
Assets$103.81M
Liabilities$8.95M
Accounts Receivable$809K
Accounts Payable$4.25M
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-09-302024-09-302023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-302009-09-302008-09-302007-09-302006-09-302005-09-302004-09-30
Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
YoY Growth----------------------
Cost of Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Gross Profit$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Gross Margin----------------------
Research and Development$37.59M$41.84M$43.72M$37.92M$32.98M$25.23M$22.26M$13.34M$10.67M$7.25M$2.27M$732K$264K$2.65M$2.6M$2.73M$2.14M$1.48M$960K$0$0$0
Selling, General, and Administrative$13.82M$11.04M$12.05M$13.07M$9.02M$5.86M$6.85M$5.99M$5.01M$8.33M$4.84M$2.24M$1.87M$1.66M$3.57M$2.91M$2.59M$3.79M$618K$25K$92K$0
Other$0$0$0$0$0$0$2.47M$1.63M$2.02M$151K$0$200K-$977K$0$0$0$0$0$0$0$0$0
Total Operating Expenses$51.41M$52.88M$55.76M$50.99M$42M$31.09M$28.81M$19.18M$15.54M$14.88M$7.11M$2.97M$2.13M$4.32M$6.18M$5.64M$4.73M$5.27M$1.58M$26K$92K$14K
Operating Income (EBIT)-$51.41M-$52.88M-$55.76M-$50.99M-$42M-$31.09M$0$0$0$0$0$0$0-$4.32M-$6.18M-$5.65M$0-$5.27M-$1.58M-$26K-$92K$0
Operating Margin----------------------
Interest Expense$0$0$964K$0$0$0$0$0$0$0$72K$7K$51K$144K$90K$292K$58K$0$0$0$0$0
Interest Income$4.68M$7.32M$6.52M$947K$26K$180K$207K$255K$88K$11K$0$0$0$0$0$0$0$0$0$0$0$0
Other Income (Expense)$5.03M$9.88M$8.26M$3.37M$4.36M$455K$2.54M$1.58M$2.05M$164K$71K$233K-$1.51M-$3.84M-$1.04M-$2.85M-$708K-$10K$1K$59$125$0
Income Before Tax (EBT)-$46.38M-$43M-$47.51M-$47.62M-$37.64M-$30.63M-$26.21M-$17.38M-$13.4M-$14.71M-$12.11M-$11.37M-$3.7M$0$0$0$0$0$0$0$0$0
Income Tax Expense$0$0$0$358K$268K-$4.35M$82K$73K$60K$30K$0$0$0$0$0$0$0$0$0$0$0$0
Net Income-$46.38M-$43M-$47.51M-$47.98M-$37.91M-$26.28M-$26.29M-$17.45M-$13.46M-$14.74M-$12.11M-$11.37M-$3.7M-$8.3M-$7.31M-$8.78M-$5.5M-$5.35M-$1.58M-$26K-$92K-$14K
Net Income Margin----------------------
Supplementary Data
EPS-0.54-0.52-0.60-0.62-0.54-0.45-0.54-0.39-0.33-0.42-0.65-1.16-0.46-1.18-1.16-1.64-1.09-1.09-0.33-0.01-0.02-0.01
Diluted EPS-0.54-0.52-0.60-0.62-0.54-0.45-0.54-0.39-0.33-0.42-0.65-1.16-0.46-1.18-1.16-1.64-1.09-1.09-0.33-0.01-0.02-0.01
Weighted Average OS85.29M83.47M79.79M76.91M69.80M58.19M48.91M44.66M40.84M35.15M18.59M9.80M7.98M7.04M6.29M5.36M5.05M4.93M4.80M4.80M4.35M1.91M
EBITDA-$46.38M-$43M-$46.54M-$47.62M-$37.64M-$31.09M-$28.88M-$19.13M-$15.57M-$15.04M-$12.11M-$11.59M-$2.14M-$472K-$5.14M-$2.79M-$4.03M-$5.26M-$1.58M-$26K-$92K-$14K
EBITDA Margin----------------------
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-09-302024-09-302023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-302009-09-302008-09-302007-09-302006-09-302005-09-302004-09-30
Assets
Current Assets
Cash and Cash Equivalents$102.58M$132.19M$151.02M$149.16M$152.11M$29.25M$22.19M$22.93M$27.44M$9.19M$15.29M$7.26M$345K$11K$135K$265K$351K$6K$25$12K$977$28K
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$102.58M$132.19M$151.02M$149.16M$152.11M$29.25M$22.19M$22.93M$27.44M$9.19M$15.29M$7.26M$345K$11K$135K$265K$351K$6K$25$12K$977$28K
Accounts Receivable$809K$2.45M$2.71M$3.19M$9.14M$4.85M$2.64M$1.87M$10K$79K$77K$0$0$0$809$38K$0$0$0$0$0$0
Inventory$0$0$0$0$16K$0-$2.64M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Assets$429K$931K$653K$162-$16K$0$2.64M$0$0$0$0$0$0$1K$55K$0$56K$0$0$0$0$0
Total Current Assets$103.81M$135.57M$154.39M$152.7M$161.62M$34.54M$25.33M$24.32M$27.79M$9.45M$15.47M$7.35M$393K$13K$201K$326K$407K$6K$25$12K$977$28K
Long-Term Assets
Property, Plant & Equipment Net$0$0$0$0$0$0$0$0$0$0$1K$2K$0$576$2K$4K$2K$862$0$0$0$0
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$3.36M$3.55B$16K$5.29M$0$52K$52K$52K$0$0$0$0$0$0$0$0$0$0$0$0
Total Long-Term Assets$0$0$3.36M$3.55B$16K$5.29M$0$52K$52K$52K$1K$2K$0$576$2K$4K$2K$862$0$0$0$0
Other Assets$0$0-$3.36M-$3.55B-$16K-$5.29M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$103.81M$135.57M$154.39M$152.7M$161.62M$34.54M$25.33M$24.38M$27.84M$9.5M$15.47M$7.35M$393K$13K$203K$330K$409K$7K$25$12K$977$28K
Liabilities
Current Liabilities
Accounts Payable$4.25M$9.63M$4.32M$3.82M$4.74M$3.99M$3.52M$2.96M$3.58M$3.06M$2.47M$0$1.71M$2K$410K$798K$1.59M$749K$463K$8K$17K$0
Short-Term Debt$0$0$0$0$0$0$0$0$0$0$85K$192K$211K$299K$868K$2.49M$2.51M$1.55M$0$20K$0$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0-$14.71M$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$805K$842K$917K$444K$444K$0$0$0$0$71K$72K-$1.22M-$1.71M-$2K$0$0-$4.1M$0$0$0$0$0
Other Current Liabilities$1.56M$1.53M$1.36M-$47$0$0$0$0$0$71K$72K$28K$0$0$68K$0$0$0$0$0$10K$0
Total Current Liabilities$8.95M$15.3M$12.53M$10.21M$10.8M$7.31M$5.04M$3.88M$3.58M$3.19M$2.66M$1.44M$1.95M$3K$1.35M$3.29M$4.1M$2K$463$28K$27K$3K
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$0$0$0$0$332$5.72M$0$0$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Long-Term Liabilities$0$0$0$0$0$0$0$0$0$0$332$5.72M$904K$0$0$0$168K$0$0$0$0$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$8.95M$15.3M$12.53M$10.21M$10.8M$7.31M$5.04M$3.88M$3.58M$3.19M$2.66M$7.16M$2.86M$2.89M$1.35M$3.29M$4.27M$2.3M$463K$28K$27K$3K
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$87K$85K$82K$78K$76K$62K$53K$46K$43K$36K$32K$47K$37K$30K$27K$24K$21K$20K$20K$19K$3K$2K
Retained Earnings-$382.45M-$336.07M-$293.07M-$245.56M-$197.59M-$159.68M-$133.4M-$108.93M-$91.48M-$78.02M-$63.28M-$52.57M-$41.2M-$37.5M-$29.2M-$21.9M-$12.56M-$7.06M-$1.71M-$132K-$106K-$14K
Comprehensive Income & Other$0$0$0$0$0$0$0$0$0$0-$2K-$768-$6K-$5K-$3K-$2K-$630$126K$0$0$0$0
Other Stockholders' Equity$477.23M$456.25M$434.84M$387.98M$348.33M$186.85M$153.63M$129.38M$115.69M$84.29M$76.06M$52.72M$38.7M$34.6M$28.03M$18.91M$8.68M$4.75M$1.23M$97K$77K$38K
Total Equity$94.87M$120.26M$141.85M$142.49M$150.82M$27.24M$20.29M$20.49M$24.25M$6.31M$12.81M$193K-$2.46M-$2.88M-$1.14M-$2.96M-$3.86M-$2.29M-$463K-$16K-$26K$26K
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$103.81M$135.57M$154.39M$152.71M$161.62M$34.54M$25.33M$24.38M$27.84M$9.5M$15.47M$7.35M$393K$13K$203K$330K$409K$7K$25$12K$977$28K
Supplementary Data
Total Debt$0$0$0$0$0$0$0$0$0$0$86K$5.91M$211K$299K$868K$2.49M$2.51M$1.55M$0$20K$0$0
Net Debt-$102.58M-$132.19M-$151.02M-$149.16M-$152.11M-$29.25M-$22.19M-$22.93M-$27.44M-$9.19M-$15.21M-$1.35M-$134K$288K$733K$2.23M$2.16M$2K-$25$8K-$977-$28K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-09-302024-09-302023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-302009-09-302008-09-302007-09-302006-09-302005-09-302004-09-30
Operating Activities
Net Income-$46.38M-$43M-$47.51M-$47.98M-$37.91M-$26.28M-$26.29M-$17.25M-$13.46M-$14.74M-$12.11M-$9.97M-$3.7M-$8.3M-$7.31M-$8.78M-$5.5M-$5.35M-$1.58M-$26K-$92K-$14K
Depreciation & Amortization$0$0$0$0$0$0$0$0$0$1K$995$768$576$2K$2K$910$410$220$0$0$0$0
Deferred Income Tax$0$0$0$0$0$0$0$0$0$0$0-$1.4M$0$0$0$0$0$0$0$0$0$0
Stock-Based Compensation$11.55M$9.44M$16.37M$18.38M$8.23M$4.88M$6.43M$5.52M$4.14M$5.06M$1.63M$638K$1M$302K$1.27M$770K$812K$0$0$0$0$0
Changes in Working Capital:
  Accounts Receivable$1.64M$260K$484K$5.94M-$4.29M-$2.21M-$772K-$231K$54K-$3K-$77K$0$0$809$37K-$38K$0$0$0$0$0$0
  Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Accounts Payable-$5.38M$5.3M$497K-$914K$751K$466K$684K$38K$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Other Working Capital-$478K-$2.81M$1.52M$331K$2.83M$1.86M$1.39M-$654K$328K$643K$1.31M-$336K$466K$2.29M$1.14M$489K-$181$460K$455K-$9K$15K$3K
Total Working Capital Change-$4.22M$2.75M$2.5M$5.36M-$706K$117K$1.3M-$847K$383K$640K$1.24M-$336K$466K$2.29M$1.18M$451K-$181$460K$455K-$9K$15K$3K
Other Non-Cash Items$0$0$845K$0$0$0$35K$0-$75K-$204K$5.01M$8.41M$1.45M$4.01M$1.05M$2.97M$1.89M$2.42M$800K$2K$16K$0
Net Cash from Operating-$39.04M-$30.81M-$27.79M-$24.24M-$30.38M-$21.29M-$18.53M-$12.58M-$9.02M-$9.24M-$4.23M-$2.66M-$778K-$1.69M-$3.8M-$4.59M-$2.79M-$2.47M-$325K-$32K-$61K-$12K
Investing Activities
Capital Expenditures$0$0$0$0$0$0$0$0$0$0$0-$3K$0$0$0-$3K-$1K-$1K$0$0$0$0
Acquisitions$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Cash from Investing$0$0$0$0$0$0$0$0$0$0$0-$3K$0$0$0-$3K-$1K-$1K$0$0$0$0
Financing Activities
Debt Repaid------------$10M----$1.42M-$1.2M-----
Common Stock Issuance$12.14M$11.97M$29.65M$22M$153.22M$28.75M$17.83M$8.17M$27.27M$3.17M$12.34M$368K$801K$996K$3.02M$3.1M$1.64M$1.13M$0$0$24K$40K
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities-$2.71M$0$0-$707K$24K-$404K-$50K-$101K$0$0$0-$789K$60K-$8K-$100K$0$300K$0$313K$24K$10K$0
Net Cash from Financing$9.43M$11.97M$29.65M$21.29M$153.24M$28.35M$17.78M$8.07M$27.27M$3.13M$12.26M$9.58M$1.11M$1.57M$3.67M$4.51M$3.14M$2.48M$313K$44K$34K$40K
Forex Effect$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash-$29.61M-$18.84M$1.87M-$2.95M$122.86M$7.06M-$745K-$4.51M$18.25M-$6.1M$8.03M$6.92M$334K-$123K-$130K-$86K$345K$6K-$12K$11K-$27K$28K
Supplementary Data
Operating Cash Flow-$39.04M-$30.81M-$27.79M-$24.24M-$30.38M-$21.29M-$18.53M-$12.58M-$9.02M-$9.24M-$4.23M-$2.66M-$778K-$1.69M-$3.8M-$4.59M-$2.79M-$2.47M-$325K-$32K-$61K-$12K
Capital Expenditure$0$0$0$0$0$0$0$0$0$0$0-$3K$0$0$0-$3K-$1K-$1K$0$0$0$0
Free Cash Flow-$39.04M-$30.81M-$27.79M-$24.24M-$30.38M-$21.29M-$18.53M-$12.58M-$9.02M-$9.24M-$4.23M-$2.66M-$778K-$1.69M-$3.8M-$4.6M-$2.8M-$2.48M-$325K-$32K-$61K-$12K
Cash at Beginning$132.19M$151.02M$149.16M$152.11M$29.25M$22.19M$22.93M$27.44M$9.19M$15.29M$7.26M$345K$11K$135K$265K$351K$6K$25$12K$977$28K$0
Cash at End$102.58M$132.19M$151.02M$149.16M$152.11M$29.25M$22.19M$22.93M$27.44M$9.19M$15.29M$7.26M$345K$11K$135K$265K$351K$6K$25$12K$977$28K